Crossmark

Therapeutic applications of engineered chimeric antigen receptors-T cell for cancer therapy

Published Online: 2022-04-11

Published Print: 2022-12

Authors

Hussain, Amina
License Information

Text and Data Mining valid from 2022-04-11

Version of Record valid from 2022-04-11
More Information

Article History

Received: 11 November 2021

Accepted: 29 March 2022

First Online: 11 April 2022

Declarations

:

: Not applicable.

: Not applicable.

: The author declare that they have no competing interests.

Document is current